Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Gene Therapy
|
January 24, 2012
PET imaging for gene & cell therapy
Sara A Collins, Kei Hiraoka, Akihito Inagaki, et al.
Biochemical and Biophysical Research Communications
|
August 4, 2007
Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions
Akihito Inagaki, Akio Soeda, Naoki Oka, et al.
Journal of Cancer
|
August 19, 2015
Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
Han-Ching Tseng, Akihito Inagaki, Vickie T Bui, et al.
Biochemical and Biophysical Research Communications
|
July 10, 2007
VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells
Naoki Oka, Akio Soeda, Akihito Inagaki, et al.
The Journal of Biological Chemistry
|
February 23, 2008
Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells
Akio Soeda, Akihito Inagaki, Naoki Oka, et al.
Cancer Immunology, Immunotherapy : CII
|
July 22, 2016
Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells
Anna K Kozlowska, Han-Ching Tseng, Kawaljit Kaur, et al.
Neuro-Oncology
|
April 8, 2017
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
Leah A Mitchell, Fernando Lopez Espinoza, Daniel Mendoza, et al.
Cancers
|
December 11, 2022
Retroviral Replicating Vector Toca 511 (<i>Vocimagene Amiretrorepvec</i>) for Prodrug Activator Gene Therapy of Lung Cancer
Hiroki Kushiya, Kei Hiraoka, Tomohiro Suzuki, et al.
Cancer Gene Therapy
|
October 11, 2014
Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector
Masamichi Takahashi, Gilmer Valdes, Kei Hiraoka, et al.
Cancer Gene Therapy
|
July 22, 2024
Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model
Hiroki Niwa, Toru Nakamura, Hiroki Kushiya, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Gene Therapy
|
January 24, 2012
PET imaging for gene & cell therapy
Sara A Collins, Kei Hiraoka, Akihito Inagaki, et al.
Biochemical and Biophysical Research Communications
|
August 4, 2007
Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions
Akihito Inagaki, Akio Soeda, Naoki Oka, et al.
Journal of Cancer
|
August 19, 2015
Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
Han-Ching Tseng, Akihito Inagaki, Vickie T Bui, et al.
Biochemical and Biophysical Research Communications
|
July 10, 2007
VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells
Naoki Oka, Akio Soeda, Akihito Inagaki, et al.
The Journal of Biological Chemistry
|
February 23, 2008
Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells
Akio Soeda, Akihito Inagaki, Naoki Oka, et al.
Cancer Immunology, Immunotherapy : CII
|
July 22, 2016
Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells
Anna K Kozlowska, Han-Ching Tseng, Kawaljit Kaur, et al.
Neuro-Oncology
|
April 8, 2017
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
Leah A Mitchell, Fernando Lopez Espinoza, Daniel Mendoza, et al.
Cancers
|
December 11, 2022
Retroviral Replicating Vector Toca 511 (<i>Vocimagene Amiretrorepvec</i>) for Prodrug Activator Gene Therapy of Lung Cancer
Hiroki Kushiya, Kei Hiraoka, Tomohiro Suzuki, et al.
Cancer Gene Therapy
|
October 11, 2014
Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector
Masamichi Takahashi, Gilmer Valdes, Kei Hiraoka, et al.
Cancer Gene Therapy
|
July 22, 2024
Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model
Hiroki Niwa, Toru Nakamura, Hiroki Kushiya, et al.
Page
of 2